![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 487/04 | (2006.01) |
A61K 31/395 | (2006.01) | ||
A61K 31/41 | (2006.01) | ||
A61K 31/4188 | (2006.01) | ||
C07H 19/23 | (2006.01) | ||
A61K 31/7052 | (2006.01) | ||
A61P 31/12 | (2006.01) |
(11) | Number of the document | 2280973 |
(13) | Kind of document | T |
(96) | European patent application number | 09735162.1 |
Date of filing the European patent application | 2009-04-22 | |
(97) | Date of publication of the European application | 2011-02-09 |
(45) | Date of publication and mention of the grant of the patent | 2012-11-28 |
(46) | Date of publication of the claims translation | 2013-02-25 |
(86) | Number | PCT/US2009/041432 |
Date | 2009-04-22 |
(87) | Number | WO 2009/132123 |
Date | 2009-10-29 |
(30) | Number | Date | Country code |
47263 | 2008-04-23 | US | |
139449 | 2008-12-19 | US |
(72) |
CHO, Aesop, US
KIM, Choung, U., US
PARRISH, Jay, US
XU, Jie, US
|
(73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Karba-nukleozidų analogai, skirti antivirusiniam gydymui |
CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT |
Payment date | Validity (years) | Amount | |
2019-04-02 | 11 | 289.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2020-04-22 |